Cocrystal Pharma Inc
(COCP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 9 | 0 | 0 | 12,605 | 15,254 |
| Cost of Goods | N/A | N/A | N/A | 9,920 | 8,428 |
| Gross Profit | 9 | N/A | N/A | 2,686 | 6,826 |
| Operating Expenses | 5,808 | 4,081 | 2,554 | 7,492 | 7,286 |
| Operating Income | -5,799 | -4,081 | -2,554 | -3,887 | -32 |
| Interest Expense | 0 | 0 | 5,231 | 1,243 | 439 |
| Other Income | 5,648 | 194 | 154 | -324 | 55 |
| Pre-tax Income | -151 | -3,887 | -7,631 | -5,454 | -416 |
| Income Tax | -52 | N/A | N/A | 3 | -96 |
| Net Income Continuous | -99 | -3,887 | -7,631 | -5,457 | -320 |
| Net Income Discontinuous | N/A | N/A | -333 | N/A | N/A |
| Net Income | $-99 | $-3,887 | $-7,965 | $-5,457 | $-320 |
| EPS Basic Total Ops | 0.00 | -0.84 | -1.56 | -1.32 | -0.12 |
| EPS Basic Continuous Ops | 0.00 | -0.82 | -1.44 | -1.30 | -0.09 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.12 | N/A | N/A |
| EPS Diluted Total Ops | -0.12 | -0.84 | -1.56 | -1.32 | -0.12 |
| EPS Diluted Continuous Ops | 0.00 | -0.82 | -1.44 | -1.30 | -0.09 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.12 | N/A | N/A |
| EBITDA(a) | $-5,600 | $-3,845 | $-2,379 | $-3,195 | $408 |